AeriSeal System
Sponsors
Aeris Therapeutics, LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology, Pulmonx Corporation
Conditions
COPDChronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease(COPD)EmphysemaEmphysema or COPDEmphysema, PulmonaryLung DiseasesPulmonary Emphysema
Phase 1
Phase 2
AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema
CompletedNCT01181466
Start: 2010-08-31End: 2011-05-31Updated: 2011-10-21
A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
TerminatedNCT01320566
Start: 2011-03-31End: 2013-11-30Target: 18Updated: 2013-11-14
Phase 4
Unknown Phase
Clinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal System
CompletedNCT02877459
Start: 2016-11-30End: 2018-08-10Updated: 2019-05-31
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
RecruitingNCT06035120
Start: 2024-02-22End: 2028-03-31Target: 200Updated: 2026-09-17